Format

Send to

Choose Destination
Transplantation. 2014 Apr 27;97(8):e47-8. doi: 10.1097/TP.0000000000000076.

HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome.

Author information

1
1 Division of Gastroenterology and Hepatology, Perelman School of Medicine at the University of PennsylvaniaPhiladelphia, PA.
PMID:
24732900
DOI:
10.1097/TP.0000000000000076
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center